Fused bicyclic kinase inhibitors

Details for Australian Patent Application No. 2011252784 (hide)

Owner OSI Pharmaceuticals, LLC

Inventors Mulvihill, Mark J.; Steinig, Arno G.; Crew, Andrew Philip; Jin, Meizhong; Kleinberg, Andrew; Li, An-Hu; Wang, Jing

Agent Spruson & Ferguson

Pub. Number AU-A-2011252784

PCT Pub. Number WO2011/143645

Priority 61/334,734 14.05.10 US

Filing date 16 May 2011

Wipo publication date 17 November 2011

International Classifications

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

A61K 31/437

A61P 35/00 Antineoplastic agents

Event Publications

13 September 2012 PCT application entered the National Phase

  PCT publication WO2011/143645 Priority application(s): WO2011/143645

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011252804-Treatment methods

2011252771-Device for compressing and drying gas